Condition: Esophageal Cancer · Esophageal Carcinoma · Postoperative Complications · Sponsor: Hospital Universitari de Bellvitge
This is a randomized controlled trial designed to compare robot-assisted thoracic approach with open transthoracic esophagectomy (Ivor Lewis technique) as a surgical treatment for resectable esophageal cancer. If our hypothesis is proved correct, robot-assisted thoracic approach will result in a lower percentage of respiratory and overall postoperative complications, lower blood loss, shorter hospital stay, but with at least similar oncologic outcomes and better postoperative quality of life compared with the open transthoracic esophagectomy (current standard).
This description comes directly from the study's public registry record.
Natàlia Cornellà, Surgeon · +34645976556 · nataliacornellagcirurgia@gmail.com
Always discuss trial participation with your own doctor first.
| Hospital Universitari de Bellvitge | L'Hospitalet de Llobregat, Barcelona, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04652180